Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02350699 · ClinicalTrials.gov registry record
Control Study of Nautilus BrainPulse for the Detection of Concussion
A clinical trial, sponsored by Jan Medical.
- Completed
- Registry status
- 22
- Enrollment target
NCT02350699: Completed study, sponsored by Jan Medical.
NCT02350699 is a clinical trial that has completed, run by Jan Medical. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02350699 has completed, sponsored by Jan Medical.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
To use the Nautilus BrainPulse to compare and contrast the signal patterns from this cohort's signal patterns with those of concussed high school athletes.
Primary Outcome
BrainPulse recordings collected in this study will be used as an age-matched control cohort for comparison with already collected concussion data that is under development for identifying a concussion algorithm. The device recordings will be visually compared for similarities and differences using data mining practices looking for features that are consistent between the concussion subjects and healthy normals.
Interventions
- DEVICE Nautilus BrainPulse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2015-01 |
| Est. Completion | 2015-05 |
What the finished NCT02350699 record still lists
NCT02350699 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Nautilus BrainPulse is the first listed.
NCT02350699 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02350699 about?
NCT02350699 is a clinical study titled "Control Study of Nautilus BrainPulse for the Detection of Concussion". To use the Nautilus BrainPulse to compare and contrast the signal patterns from this cohort's signal patterns with those of concussed high school athletes.
What is the current status of trial NCT02350699?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2015-01. Estimated completion is 2015-05.
What interventions are being tested in trial NCT02350699?
The interventions under investigation include: Nautilus BrainPulse (DEVICE).
Who is sponsoring clinical trial NCT02350699?
This trial is sponsored by Jan Medical, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia